Use this dropdown to select your preferred language.
Roquette is a leading provider of plant-based ingredients, excipients and pharmaceutical solutions dedicated to enhancing the quality and convenience of essential products for consumers and patients worldwide.
Roquette employs more than 11,000 people globally, operating in more than 150 countries through more than 40 manufacturing sites and 20 R&D and innovation centers. The company achieved a turnover of €4.5 billion in 2024.
在默沙东（默沙东是美国新泽西州罗威市默克公司的公司商号），我们齐心协力追求共同的目标：我们发挥前沿科学的力量，在全球范围内拯救生命、改善生活。一个多世纪以来，我们始终处于研发前线，为攻克全球最为棘手的疾病带来药物、疫苗和创新的健康解决方案。
BASF has been a committed partner to Greater China since 1885. With larger production sites in Shanghai, Nanjing, Chongqing and Zhanjiang (under construction), BASF is a major foreign investor in the country’s chemical industry, and operates the Innovation Campus Shanghai, BASF’s largest R&D site in Asia.
BASF posted sales of approximately €8.6 billion in 2024 to customers in Greater China and employed 12,687 people as of the end of the year.
With $15 billion in net sales in 2022, we are the world’s leading pure-play consumer health company by revenue. Kenvue became a fully independent company following its listing on the NYSE in May 2023. Throughout a history spanning over 135 years, we have been a part of consumers’ daily rituals and in the moments that matter most. Today, Kenvue touches the lives of approximately 1.2 billion people in 165 countries and regions.
Merz Aesthetics (Shanghai) Co., Ltd.
Covestro is one of the world’s leading manufacturers of high-quality plastics and their components. With its innovative products, processes and methods, the company helps enhance sustainability and the quality of life in many areas. The company, based in Leverkusen, Germany, is committed to becoming fully circular and helping to make the circular economy a global guiding principle.
GEA is one of the world’s largest systems suppliers for the food, beverage and pharmaceutical sectors. Our portfolio includes machinery and high-tech plants as well as advanced process technology, components and comprehensive services for tomorrow’s food and beverage assortment. Used across diverse industries, they enhance the sustainability and efficiency of production processes globally.
作为全球领先的高端智能制造及工业互联网服务商，工业富联（全称：富士康工业互联网股份有限公司，股票代码：601138）坚持“数据驱动、绿色发展”的战略方向，业务已实现对数字经济产业五大类——云及边缘计算、工业互联网、智能家居、5G及网络通讯设备、智能手机及智能穿戴设备的全覆盖，在产品、技术以及全球市占率方面极具优势。
自2018年上市以来，公司依托于数字经济新基建的发展机遇，推动“高端智能制造+工业互联网”的四大核心业务高质量发展，实现产品技术的持续创新，公司业绩稳步增长。受益于AI算力需求强劲增长带动公司盈利能力提升，2024年全年营业收入6091.35亿元，同比增长27.88%；归母净利润232.16亿元，同比增长10.34%，营收利润均创新高。
勃林格殷格翰是全球领先的生物制药企业，布局人用药品、动物保健两大业务领域。公司研发投入位居行业前列，致力于研究突破性疗法，解决巨大未满足的医疗需求，从而帮助改善或延长生命。自1885年成立以来，勃林格殷格翰一直是独立的家族企业，始终着眼长远发展，将可持续发展理念贯穿全价值链。公司在全球有近5.45万名员工，服务逾130个市场，致力于打造一个更健康、更可持续、更公平的未来。勃林格殷格翰于1994年进入中国，总部位于上海，业务遍布全国，拥有约3,200名员工。公司致力于人用药品、动物保健、生物制药合同开发与生产三大业务，实现研发、生产、商业运营、外部创新合作的全价值链布局。中国是勃林格殷格翰的重点市场和创新高地之一，公司将中国患者的需求纳入全球研发策略，致力于把更多更好的创新产品更早地带给中国的患者，助力中国健康产业的高质量发展，全面改善人与动物的健康。
苏尔寿是全球关键基础设施和大型重要行业核心工艺应用领域的领导者。我们确保关键产品与服务的安全性及品质，并推动向循环经济的转型。通过遍布全球的160家世界级制造基地和服务中心组成的响应网络，客户能充分受益于我们对创新、性能和品质的坚定承诺。
About Takeda
Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology.
QuidelOrtho Corporation (NASDAQ: QDEL) (“QuidelOrtho”) announced completion of the transaction combining Quidel Corporation (“Quidel”) and Ortho Clinical Diagnostics Holdings plc (“Ortho”), creating QuidelOrtho, a leading in vitro diagnostics company. The new company, headquartered in San Diego, California, generated more than $2.8 billion in 2024 and has approximately 7,000 employees.